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HEART FAILURE
Naroparcil, a P-D Xyloside Analog, Limits Intimal
Hyperplasia After Arterial Injury
Pierre Belichard, Marianne Ziol, Ouafae Tahlil, Claude Robert, Philippe Masson,
Didier Pruneau, Patrick Bruneval, P Gabriel Steg, FaculM Xavier Bicha1- Pans, France
Controls Naroparcil p
Angiography (mm)
Minimal lumen diameter: OA5 ± 0.07 075 ± 006 <0.05
Histomorphometry (mm2)
Lumen area: OA7±018 087 ± 033 <0.05
Intimal thickness {mml: 0.61 ± 0.04 OAO ± 003 <0.01
Media area: 076 ± 023 0.65 ± 0.18 NS
Media HHF-35-stained area (%) 22 ± 6 43 ± 7 <0.01
Media RAM-l1-stained area (%) 12 ± 2 29 ± 9 <0.01
Media PG6S-stained area (%1 13 ± 2 14 ± 3 NS
ABSTRACTS 9A
There was no difference in immunostaining of the intima.
In this model, treatment with naroparcil resulted in decreased intimal thick-
ening and preserved vascular lumen. The mechanism of this effect is proba-
bly not linked to PG metabolism but to medial preservation.
ANGIOPLASTY - STENTS AND ATHERECTOMY, LASERS
AND OTHER
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Inhibition of proteoglycan (P) synthesis by fJ-O xylosides (Xyll is associated
with growth inhibition in several cultured vascular cell lines. We examined
the effects of naroparcil (an orally active Xyli on intimal hyperplasia induced
by balloon iliac injury in hypercholesterolemic rabbits.
36 rabbits fed a cholesterol-enriched diet were randomly assigned to either
placebo or 300 mg/kg naroparcil. After 14 days, iliac injury was induced by bi-
lateral endothelial abrasion using a 4F latex balloon. Eight weeks later, serum
cholesterol levels did not differ between groups. Quantitative angiography
as well as quantitative histomorphometry, with immunostaining of smooth
muscle cells (HHF-35). macrophages (RAM-l1) and proteoglycans (PG-6S)
were performed. Results are (mean ± SO):
Thus, we have for the first time demonstrated that inhibition of the ex-
trinsic coagulation pathway with OEGR-Vlla significantly limits the restenotic
processes in this experimental model.
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Percent total monos
74± 8% 21 ± 1%
64±2'10 19±9'10
80±8% 18±1'10
78 ± 2% 11 ± 2%
Percent total pmns
90 ± 2% 10 ± 2%
84±3'10 13±3%
90± 2% 10± 1%
87 ± 2% 10 ± 2%
Peak 3Peak 1 Peak 2
Platelet fluorescence intensity on monos
Ca:pre 25 ± 8 290 ± 84 539 ± 276
Ca:post 27 ± 7 230 ± 81 1072 ± 390'
CS:pre 19±6 318±78 602±299
CS:post 25 ± 7 293 ± 80 870 ± 370'
Platelet fluorescence intensity on pmns
Ca:pre 12 ± 2 235 ± 57 529 ± 276
Ca:post 17 ± 2 350 ± 75 946 ± 253'
CS:pre 12±2 232±67 O± 0
CS:post 12 ± 2 296 ± 80 800 ± 270'
*p ~ 0.02, 'p = 0.02
Leukocyte Activation with Platelet Adhesion After
Coronary Angioplasty, a Mechanism for
Recurrent Disease?
Judith K. Mickelson, Nasser M. Lakkis, Gerardo Villarreal-Levy, Bonnie J. Hughes,
C. Wayne Smith. Baylor College of Medicine & VAMC, Housron, TX
Increased expression of COll b/C018 (Mac-l) on monocytes (mono) and
neutrophils (pmn) promotes their adhesion to endothelial cells. Thrombin ac-
tivated platelets adhere to monos and pmns via P-selectin. These complexes
may affect the inflammatory process after coronary angioplasty (PTCA). Dur-
ing 10 elective single vessel PTCAs blood was obtained from femoral vein,
coronary artery (Ca) and coronary sinus (CS) before and after PTCA. Two
color flow cytometry with direct labeled monoclonal antibodies and isotype
matched control antibodies was used to detect C011 b/C018, L-selectin and
platelets bound to monos and pmns. COll b/C018 expression increased af-
ter the procedure at all three sample sites on monos (p = 0.001) and pmns
(p = 0.02). In each patient the increase in C011 b/C018 on either cell type
was similar (p = 0.002, r = 0.7). L-selectin shedding was not detected. Cy-
tometric histograms showed 3 peaks of platelet fluorescence intensity on
leukocytes. Before PTCA (pre) most leukocytes had few adherent platelets.
The percentage of leukocytes with adherent platelets (*p = 0.02) and the in-
tensity of bound platelet fluorescence (,p = 0.02), i.e. the number of platelets
per leukocyte, increased in samples from the Ca and CS after PTCA, despite
standard aspirin and heparin therapy. In conclusion, leukocyte activation with
platelet adhesion does occur after PTCA.
Yangsoo Jang, Luis A. Guzman, A. Michael Lincoff, Michael Gottsauner-Wolf,
Farhard Forudi, Charles E. Hart, Stephen G. Ellis, Eric J. Topol. Cleveland Clinic
Foundation, Cleveland, OH; Zymogenetics, Seatle, WA
Low-dose Radioactive Palmaz-Schatz Stents
Prevent Smooth Muscle Cell Proliferation and
Neointimal Hyperplasia in Rabbits
Christoph Hehrlein, Klaus Donges, Christina Gollan, Jurgen Metz,
Peter Fehsenfeld, Dept of Cardiology, University of Heidelberg, and Nuclear Research
Center Karlsruhe, Germany
The long-term consequences of ionizing irradiation of arteries with doses of
more than 10 Gray (Gy) are vascular stenosis. To evaluate anti-proliferative
effects of much lower irradiation doses, we implanted radioactive Palmaz-
Schatz stents (RS) emitting doses of 0.002 Gy/h in rabbit arteries (n = 20).
The radiation dose absorbed in the arteries after 100 days is lower than a hu-
man chest dose after a single cardiac catheterization. Arterial smooth muscle
cell (SMC) proliferation and neointimal hyperplasia were compared 1 and 12
weeks after RS and non-radioactive stent (NRS) implantation. SMC prolifer-
ation was assessed by immunostaining with antibodies to proliferating cell
nuclear antigen (PCNA) and SMC-a-actin and by computer-assisted count-
ing of neointimal cells (NICI/O.l mm2 neointima. Quantitative morphometry
of arterial cross-sections was applied to compare the neointimal areas after
implantation of RS and NRS. After 1 week, 30% neointimal SMCs were pos-
itive for PCNA in NRS, whereas 0.5% SMCs were PCNA-positive in NRS (p <
0.01). After 12 weeks, 850 ± 50 NIC (mean ± SOl were found in arteries with
NRS compared to 237 ± 26 NIC in arteries with RS (p < 0.01). The neointimal
area was 0,8 ± 0,2 mm2 12 weeks following implantation of NRS versus 0.4
± 0.2 mm2 following RS implantation (p < 0.01).
Concfusion: A low-dose endovascular irradiation via radioactive stents pre-
vents smooth muscle cell proliferation and stenotic neointimal thickening
after angioplasty. The results do not confirm previous reports of vascular
stenosis after ionizing irradiation.
Usefulness of On-line 3D Reconstruction for
Stent Implantation
Francesco Prati, Carlo di Mario, Clemens von Birgelen, Robert Gil, Pim J. de Feyter,
Peter de Jaegere, Wim van der Giessen, Patrick W Serruys. Thoraxcenter,
Rotterdam, The Netherlands
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Extrinsic Coagulation Pathway Inhibition Using
Inactivated Factor Vila Limits Restenosis in the
Rabbit Atherosclerosis Model
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An inactivated factor Vila (OEGR-Vlla). which inhibits tissue factor initiation of
the extrinsic coagulation pathway, has potential to block the response to vas-
cular injury at the highest level of the coagulation cascade. We evaluated the
effects of OEGR-Vlla on the restenosis process following balloon angioplasty
(BAI in the rabbit. Focal femoral atherosclerosis was induced in 15 rabbits by
air dessication method followed by 1% cholesterol diet for 28 days, BA of
each femoral artery was then performed, using a 2.5 mm balloon with three
inflations at 6 atm for 60 sec, Rabbits were randomized to two treatment
groups: a control group (n = 8). and a OEGR-Vlla group (n = 7). In the control
group, 150 U/kg of heparin was injected intravenously to prevent thrombus
formation during the procedure, followed by a 3 day intravenous infusion
of saline. In the OEGR-Vlla group, 1 mglkg of OEGR-Vlla was injected intra-
venously as a bolus and 50 /Lglkg!hr of OEGR-Vlla was infused for 3 days.
Angiograms were performed before (pre-BA). after (post-BA), and 21 days
after BA (21 d) immediately prior to sacrifice. Femoral arteries (13 in control
vs 10 in OEGR-Vlla treated groups) were pressure fixed in situ. Angiographic
analysis of minimal luminal diameter(MLO, mm) at pre-BA. immediately post-
BA, and 21 days post BA and planimetric analysis of cross-sectional area of
neointima (%CSA) in histologic sections of the femoral arteries are shown
below (mean ± SO):
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Pre-SA Post-SA 21 d %CSA The additional information provided by 3-D reconstruction of intracoronary
ultrasound images (ICUS) during stent implantation, was assessed in 8 pts.
In total 14 stents were used: 6 Palmaz-Schatz, 3 AVE and 5 Wallstent. The
images of all 14 coronary segments encompassing the full stent length and
the adjacent reference segments were acquired by using a motorized pull-
back at a constant speed (1 mm/s) and immediately processed in the inter-
ventional suite using an automated contour detection algorithm based on
acoustic quantification (Figure). Residual percent area stenosis (%AS) of the
stented segment, automatically measured on-line after 3-D reconstruction.
was compared with ICUS measurements obtained by direct review of the
video-tape. In three pts studied before stent implantation on-line 3-D recon-
struction facilitated the selection of the stent length by measuring length of
dissection and distance between stenosis and left main or diagonal branch.
After stent implantation. the absence of stent overlapping in three patients
receiving multiple stents and the relationship with side branches could be
assessed. The visual information from the 3-D longitudinal views and the
on-line measurements triggered additional balloon inflations in 5 pts. The
selection of frames and the measurement from tape required a longer time
than 3-D reconstruction and measurement (4.4 vs 2.35 min. p < 0.0011 and
resulted in a slight underestimation of the residual %AS with 3 pts showing a
>20% %AS with 3-D not recognized from tape analysis, Conclusion: On-line
3-D reconstruction of ICUS for intracoronary stenting facilitates stent selec-
tion, evaluates adequate stent deployment by rapidly and accurately measur-
ing residual intrastent stenosis and detecting its relationship with anatomic
landmarks.
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CARDIAC PACING
Dual-Chamber Pacing for Patients with
Hypertrophic Obstructive Cardiomyopathy: A
Prospective Randomized, Double-Blind
Crossover Trial
Rick A. Nishimura. Jane M. Trusty, David L. Hayes. Thomas G. Allison, David
R. Holmes Jr.. Sharonne N. Hayes, Raul E. Espinosa, John D. Symanski, A.
Jamil Tajik. Mayo Clinic. Rochester, MN
Implantation of a dual-chamber permanent pacemaker (PPM) has recently
been proposed as a therapeutic alternative for patients with hypertrophic ob-
structive cardiomyopathy (HOCM). To objectively determine the short-term
benefit of PPM, we entered 11 patients with severely symptomatic HOCM
(mean age, 53 ± 13 years; 7 males, 4 females) into a prospective randomized,
double-blind crossover trial with 2 months of continuous atrial synchronous
pacing (000) and 2 months of backup pacing (WI). All medications were
continued throughout the study. Clinical symptoms. oxygen consumption
treadmills. and Doppler echocardiography were performed at baseline and
after each ofthe two arms. During the 000 arm. 62% experienced subjective
symptomatic improvement and 37% admitted to symptomatic improvement
in the WI arm. The data at baseline and after each of the two arms for maxi-
mum treadmill time (TMET-max). maximum oxygen consumption (V02-maxl,
and Doppler outflow tract gradient (GRAD) are shown:
TMET-max (min) V02-max (mUkg/min) GRAD (mmHg)
BASE 5.7 ± 1.9 19.0 ± 5.8 76 ± 20
WI 60 ± 2.3 200 ± 5.8 56 ± 25
DOD 60 ± 1.7 200 ± 60 47 ± 27'
*p < 0.05 VS. baseline
James W. Vetter, Tomoaki Hinohara. Expedito E. Ribeiro. S. Chiu Wong. Martin
B. Leon. Joseph P. Carrozza Jr., Donald S. Baim. Patrick W. Serruys, Peter De
Jaegere, Jean Fajadet. Jean Marco. John B. Simpson. Sequoia Hospital and the
Pacific Foundation for Cardiovascular Research, Redwood City, CA
A new device (prostar'", Perclose. Inc.) was developed to close femoral
artery access sites percutaneously following coronary interventions in fully
anticoagulated patients. The catheter deploys four needles with two pairs
of sutures around the hole of femoral artery access sites. The sutures are
then tied to close the arteriotomy site mechanically to achieve immediate
hemostasis. As a pilot phase, the device was tested in six centers. The device
was used immediately following coronary intervention in 91 access sites.
Despite an average ACT at the time of the procedure of >300 seconds. im-
mediate complete hemostasis was achieved in 82 sites (90%). The devices
were not appropriately positioned in 8 cases and procedures were aborted
followed by reinsertion of a sheath or manual compression. Two patients
(2.2%) required surgical repair of the femoral artery; one with device me-
chanical failure and one with bleeding from the initial puncture site in the
posterior wall despite successful closure of the sheath site in the front wall.
There were no AV fistulae or pseudoaneurysms requiring surgery and no in-
fection, distal embolism or need for blood transfusion.
In conclusion. this pilot study suggests that this suture mediated closure
device appears to provide safe and effective hemostasis at the femoral ac-
cess site in fully anticoagulated patients following coronary interventions.
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Atrial Synchronous Versus AV Sequential Pacing
for Hypertrophic Cardiomyopathy (HOCM)
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Alan Micklin, Robert C. Sheppard. Robert Foley, Scott E. Hessen. Sina Zaim. Kevin
D. Kravitz, Steven P. Kutalek. Hahnemann University, Philadelphia, PA
Dual chamber(DC) pacing has proven effective in reducing the left ventricular
outflow tract gradient (LVOTG) in most patients (pts) with HOCM refractory
to drug therapy. However, optimal pacemaker (PM) programming including
pacing mode and atrioventricular delay (AVO) has not been established. Ac-
cordingly, we performed continuous-wave transthoracic Doppler echocardio-
graphy on 7 pts with DC PMs (5 male, 2 female, mean age 64.7 ± 12.7 yearsl
with HOCM and a resting peak LVOTG exceeding 25 mmHg to evaluate the
effects on peak LVOTG of atrial synchronous pacing (VDD) and AV sequential
pacing (000) at 10 bpm above sinus rhythm while varying the AVO in steps
of 20 msec to a minimum of 40 msec.
Conclusion: PPM for patients with HOCM provides subjective improve-
ment and decrease in gradient for a select group of patients. However. not
all patients will respond to PPM, and there is no overall statistically signifi-
cant improvement in objective exercise parameters on short-term follow-up.
000 PPM should not be routinely implanted in all patients with HOCM until
further results of larger prospectively randomized trials are available.
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Conclusions: 1) At AVO of 100 to 140 msec, 000 pacing significantly re-
duced the peak LVOTG while VDD pacing did not. 2) At AVO less than 100
msec, VDD pacing significantly reduced peak LVOTG only at AVO of 40 msec,
while 000 pacing at 10 bpm above sinus rhythm reduced peak LVOTG at all
AVO used. Therefore PMs which have the capabilityto program different AVO
for VDD and 000 modes and that provide programmable AVOs less than 60
msec are optimal for HOCM pts.
Percutaneous Vascular Surgery: Suture Mediated
Percutaneous Closure of Femoral Artery Access
Site Following Coronary Intervention
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